Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Santoni

Showing results (41-50 of 459) with videos related to

Pageof 46
Sort By:
Annals of Translational Medicine|April 30, 2019
Pathological nodal staging score for renal cell carcinoma: how to build reliable therapeutic choices basing on assumptionsMelissa Bersanelli, Sebastiano Buti, Matteo Santoni, et al.
Biology|February 12, 2026
Association Between Systemic Immune-Inflammatory Index (SII) and Cancer Grading and Staging: Evidence from the Current Scientific LiteratureAlessandro Rizzo, Elsa Vitale, Lorenza Maistrello, et al.
European Urology|April 3, 2022
Re: Effect of Immunotherapy Time-of-day Infusion on Overall Survival Among Patients with Advanced Melanoma in the USA (MEMOIR): A Propensity Score-matched Analysis of a Single-centre, Longitudinal StudyMatteo Santoni, Javier Molina-Cerrillo, Francesco Massari, et al.
Current Topics in Medicinal Chemistry|February 26, 2013
Oncogenic and anti-oncogenic effects of transient receptor potential channelsSonia Liberati, Maria Beatrice Morelli, Massimo Nabissi, et al.
CNS & Neurological Disorders Drug Targets|March 9, 2013
TRP channels: new potential therapeutic approaches in CNS neuropathiesMaria Beatrice Morelli, Consuelo Amantini, Sonia Liberati, et al.
Expert Review of Anticancer Therapy|August 28, 2014
Highlights from the ASCO Genitourinary Symposium 2014: focus on renal and prostate cancerRoberto Iacovelli, Matteo Santoni, Filippo de Braud, et al.
European Urology|July 19, 2018
Re: Gladell P. Paner, Walter M. Stadler, Donna E. Hansel, Rodolfo Montironi, Daniel W. Lin, Mahul B. Amin. Updates in the Eighth Edition of the Tumor-node-metastasis Staging Classification for Urologic Cancers. Eur Urol 2018;73:560-9: Tumour, Node, and Metastasis Staging System for Urological Malignancies: Are We Ready for the Next Step?Vincenzo Di Nunno, Matteo Santoni, Alessia Cimadamore, et al.
Frontiers in Oncology|May 16, 2020
Emerging Role of Mucolipins TRPML Channels in CancerGiorgio Santoni, Matteo Santoni, Federica Maggi, et al.
Current Drug Targets|February 11, 2015
Morphological and molecular backgrounds for personalized therapies in genitourinary cancersRodolfo Montironi, Marina Scarpelli, Matteo Santoni, et al.
European Urology Oncology|August 15, 2019
Re: Christopher C. Parker, Nicholas D. James, Christopher D. Brawley, et al. Radiotherapy to the Primary Tumour for Newly Diagnosed, Metastatic Prostate Cancer (STAMPEDE): A Randomised Controlled Phase 3 Trial. Lancet 2018;392:2353-66: Metastatic Hormone-naïve Prostate Cancer: A Multimodal Approach for a Heterogeneous DiseaseVincenzo Di Nunno, Matteo Santoni, Lidia Gatto, et al.
Pageof 46

Showing results (41-50 of 459) with videos related to

Sort By:
Pageof 46
Annals of Translational Medicine|April 30, 2019
Pathological nodal staging score for renal cell carcinoma: how to build reliable therapeutic choices basing on assumptionsMelissa Bersanelli, Sebastiano Buti, Matteo Santoni, et al.
Biology|February 12, 2026
Association Between Systemic Immune-Inflammatory Index (SII) and Cancer Grading and Staging: Evidence from the Current Scientific LiteratureAlessandro Rizzo, Elsa Vitale, Lorenza Maistrello, et al.
European Urology|April 3, 2022
Re: Effect of Immunotherapy Time-of-day Infusion on Overall Survival Among Patients with Advanced Melanoma in the USA (MEMOIR): A Propensity Score-matched Analysis of a Single-centre, Longitudinal StudyMatteo Santoni, Javier Molina-Cerrillo, Francesco Massari, et al.
Current Topics in Medicinal Chemistry|February 26, 2013
Oncogenic and anti-oncogenic effects of transient receptor potential channelsSonia Liberati, Maria Beatrice Morelli, Massimo Nabissi, et al.
CNS & Neurological Disorders Drug Targets|March 9, 2013
TRP channels: new potential therapeutic approaches in CNS neuropathiesMaria Beatrice Morelli, Consuelo Amantini, Sonia Liberati, et al.
Expert Review of Anticancer Therapy|August 28, 2014
Highlights from the ASCO Genitourinary Symposium 2014: focus on renal and prostate cancerRoberto Iacovelli, Matteo Santoni, Filippo de Braud, et al.
European Urology|July 19, 2018
Re: Gladell P. Paner, Walter M. Stadler, Donna E. Hansel, Rodolfo Montironi, Daniel W. Lin, Mahul B. Amin. Updates in the Eighth Edition of the Tumor-node-metastasis Staging Classification for Urologic Cancers. Eur Urol 2018;73:560-9: Tumour, Node, and Metastasis Staging System for Urological Malignancies: Are We Ready for the Next Step?Vincenzo Di Nunno, Matteo Santoni, Alessia Cimadamore, et al.
Frontiers in Oncology|May 16, 2020
Emerging Role of Mucolipins TRPML Channels in CancerGiorgio Santoni, Matteo Santoni, Federica Maggi, et al.
Current Drug Targets|February 11, 2015
Morphological and molecular backgrounds for personalized therapies in genitourinary cancersRodolfo Montironi, Marina Scarpelli, Matteo Santoni, et al.
European Urology Oncology|August 15, 2019
Re: Christopher C. Parker, Nicholas D. James, Christopher D. Brawley, et al. Radiotherapy to the Primary Tumour for Newly Diagnosed, Metastatic Prostate Cancer (STAMPEDE): A Randomised Controlled Phase 3 Trial. Lancet 2018;392:2353-66: Metastatic Hormone-naïve Prostate Cancer: A Multimodal Approach for a Heterogeneous DiseaseVincenzo Di Nunno, Matteo Santoni, Lidia Gatto, et al.
Pageof 46